Wire Stories

Category Added in a WPeMatico Campaign

JPEG_Full_Color

ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors

Based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s ENHERTU that showed clinically meaningful responses across a broad...

logo-21

Global Microbiome Manufacturing Markets 2023-2024 & 2035: Industry Trends, Forecasts, Formulation, Primary Packaging Used, Scale of Operation, Company Size, Key Regions and Leading Developers – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Microbiome Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product Manufactured,...